C5 (UK) will be
holding its 25th Congress on Biotech & Pharma Patenting on December 4, 2013
in London, UK. During the Congress, C5
faculty will offer presentations on the following topics:
• How to
successfully time your antibody patent filing strategies;
• European Patent Office
keynote address;
• How to optimise
your patent portfolio by taking advantage of the latest patent expiry
strategies;
• Taking action now
to incorporate the Unitary Patent and Unified Patent Court into your current
patent filing strategies;
• Opportunities to
expand your patent portfolio via the patent eligibility of personalised
medicines and biomarkers;
• Breaking down the
impact of the Myriad decision on European
companies and their human gene developments;
• Practical impact
and benefits of the forthcoming UK Bolar amendments; and
• How to enforce
your biotech products: Key developments and trends in litigation strategies.
In addition, a Pre-Congress masterclass providing a "Step-by-Step Guide to Developing and Maintaining an Effective Freedom to Operate Strategy for Biotech Products" will be held from 2:00 to 5:00 pm on December 3, 2013. The masterclass will walk attendees through the latest trends, pitfalls, and techniques for developing the most time efficient and cost effective FTO strategy possible.
A complete brochure for the Biotech & Pharma Patenting conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The registration
fee is £1095 (conference alone), £1595 (conference and masterclass), or £695 (conference
webcast). Those registering by November
8, 2013 will receive a £100 discount.
Those interested in registering for the conference can do so here,
by e-mailing registrations@C5-Online.com, by calling +44 20 7878 6888, or by
faxing a registration form to +44 20 7878 6885.
Patent Docs is a media partner of the C5 Biotech & Pharma Patenting conference.
Comments